The NDA includes a combination of Blenrep with bortezomib plus dexamethasone (BorDex) or pomalidomide plus dexamethasone ...
British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...
Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
Some major insurers and pharmacies err toward keeping name-brand medications such as ArmonAir Digihaler and Arnuity Ellipta ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
Staff manufacture antibiotics under the brand name Zinnat ... for the authority said the masterplan was "a major part of the work of the GSK Taskforce" which also comprises the Cumbria Local ...
Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza ... and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is ...